| JTS2200100 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2200101 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2200102 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2022-10-27 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2300048 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2023-08-30 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;Patheon Italia SpA;Abbvie Inc | | | view |
| JTS2300061 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Disposable Import Drug Application | 2023-11-16 | | AbbVie Pharmaceutical Trading (Shanghai) Co Ltd;AbbVie Biotechnology Ltd;Abbvie Inc | | | view |
| JXSB2000054 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2021-05-09 | view |
| JXSB2000055 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2020-12-25 | AbbVie Inc. | Abbvie Inc;Boehringer Ingelheim Pharma Gmbh & Co KG | In Review | 2021-05-09 | view |
| JXSB2101107 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-12-10 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2101108 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-12-10 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2300056 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Patheon Italia SpA;Abbvie Inc | | | view |
| JXSB2300057 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2300058 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2300059 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Patheon Italia SpA;Abbvie Inc | | | view |
| JXSB2300060 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2300061 | Risankizumab注射液（ABBV-066) | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2023-05-16 | | Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2400026 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-03-09 | | AbbVie Biotechnology Ltd;Boehringer Ingelheim Pharma Gmbh & Co KG;Abbvie Inc | | | view |
| JXSB2500069 | Risankizumab注射液 | risankizumab | Injection | Biological Products | Supplementary Application | 2025-07-22 | | AbbVie Biotechnology Ltd;Abbvie Deutschland Gmbh & Co KG;Abbvie Inc | | | view |
| JXSL1800063 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-10 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-08 | view |
| JXSL1800064 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
| JXSL1800065 | Risankizumab注射液（ABBV-066） | risankizumab | Injection | Biological Products | Import Drug Application | 2018-12-14 | AbbVie Inc. | Abbvie Inc | In Review | 2018-12-13 | view |
